Research

Hormonal

Silencing or deficiency of the mitochondrial Complex IV subunit COX5B in white adipose tissue drives intracellular lipid accumulation and adipocyte enlargement, whereas restoring COX5B expression counteracts age-dependent obesity.

This research suggests that age-related weight gain is driven by a specific decline in mitochondrial efficiency (Complex IV) in fat cells, regulated by the HIF1A protein. While you cannot directly 'dose' COX5B, the findings imply that strategies supporting mitochondrial health and reducing chronic hypoxic stress in adipose tissue may help prevent age-related fat accumulation. For humans, higher COX5B levels are associated with better weight loss outcomes after bariatric surgery, suggesting this biomarker has prognostic value.

GoodSupportsHIGH confidence
Silencing of Cox5b decreased fatty acid oxidation and promoted intracellular lipid accumulation. Moreover, local in vivo Cox5b silencing in WAT of young mice increased the size of adipocytes, whereas restoration of COX5B expression in aging mice counteracted adipocyte enlargement.
Inés Soro-Arnáiz et al. · Cell Reports · 2016

Why this rating

Strong mechanistic evidence in mice (knockout, silencing, restoration) and correlational human data, but lacks direct human interventional trials.

Source

Role of Mitochondrial Complex IV in Age-Dependent Obesity

Inés Soro-Arnáiz et al. · Cell Reports · 2016

DOI 10.1016/j.celrep.2016.08.041

mechanism_onlyCited 89×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →